1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBMS Corporate Giving Grant is sponsored by Bristol Myers Squibb Foundation. Enhances healthcare and advances scientific knowledge through support for various organizations.
Get alerted about grants like this
Save a search for “Bristol Myers Squibb Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Nonprofit organizations and educational institutions. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Transforming access to sickle cell care in sub-Saharan Africa is sponsored by Bristol Myers Squibb Foundation. The Bristol Myers Squibb Foundation, in partnership with Baylor College of Medicine Global Health and Texas Children's Global HOPE program, launched an initiative in October 2024 to transform pediatric SCD care in Sub-Saharan Africa. The initiative focuses on building local healthcare capacity and integrating lifesaving SCD interventions into primary health services. Initial launches are in Tanzania and Uganda, with a phased approach for a broader pan-African program.
Sickle Cell Disease program (part of Pediatric Cancers and Blood Disorders focus area) is sponsored by Bristol Myers Squibb Foundation. The BMS Foundation, in partnership with Baylor College of Medicine Global Health and Texas Children's Global HOPE Program, supports initiatives to transform pediatric care for sickle cell disease (SCD) in sub-Saharan Africa. This includes building local healthcare capacity and integrating SCD interventions into primary health services.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.